A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2004
11/11/2004	DE10111780B9 Brausetablette, Pille oder Dragee, sowie das Verfahren zu ihrer Herstellung Effervescent tablet, pill or coated tablet, and the process for their preparation
11/11/2004	CA2752134A1 A non-smokable electronic spray cigarette
11/11/2004	CA2638788A1 Formation of strong superporous hydrogels
11/11/2004	CA2524241A1 Extended release venlafaxine tablet formulation
11/11/2004	CA2523869A1 Tablets and methods for modified release of hydrophilic and other active agents
11/11/2004	CA2523830A1 Methods and compositions using gonadotropin hormone releasing hormone
11/11/2004	CA2523510A1 Use of an amorphous polyester as a polymer base for masticatory substances
11/11/2004	CA2523502A1 Reactor coated with a polymer
11/11/2004	CA2523432A1 Solid drug formulation and device for storage and controlled delivery thereof
11/11/2004	CA2523413A1 Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds
11/11/2004	CA2523374A1 Method for the dispersion of water-soluble or hydrophilic substances in a supercritically pressurized fluid
11/11/2004	CA2523372A1 Fast dissolving orally consumable films containing a modified starch for improved heat and moisture resistance
11/11/2004	CA2523367A1 Confectionery products for delivery of pharmaceutically active agents to the throat
11/11/2004	CA2523363A1 Compositions, targets, methods and devices for the therapy of ocular and periocular disorders
11/11/2004	CA2523339A1 Agent for preventing and healing constipation
11/11/2004	CA2523151A1 Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
11/11/2004	CA2522868A1 Vector comprising gastric protection for oral administration
11/11/2004	CA2522043A1 Method and composition for preventing, reducing and reversing ocular ischemic neuronal damage
11/11/2004	CA2521735A1 Fast dissolving orally consumable films containing a sucralose as a sweetener
11/11/2004	CA2521624A1 Pharmaceutical compositions releasing their active agents from a buccal or sublingual location to overcome an absorption window problem
11/11/2004	CA2521574A1 Oral pharmaceutical delivery system with improved sustained release
11/11/2004	CA2521560A1 Hsa-free stabilized interferon liquid formulations
11/11/2004	CA2520779A1 Agent for intra-airway administration
11/11/2004	CA2511353A1 Solid dosage form comprising desmopressin and method for manufacturing thereof
11/10/2004	EP1475434A1 Method for storing tumor cells
11/10/2004	EP1475114A2 Injection system suitable for the administration of semisolid, sustained-release pharmaceutical compositions of gelable peptide salts
11/10/2004	EP1475104A1 Stabilized proteinic preparation
11/10/2004	EP1475101A1 Antibody-containing solution pharmaceuticals
11/10/2004	EP1475100A1 Antibody-containing solution pharmaceuticals
11/10/2004	EP1475099A1 Use of botulinum toxin to treat urinary incontinence
11/10/2004	EP1475098A1 High-concentration preparation of soluble thrombomodulin
11/10/2004	EP1475095A1 Percutaneous preparations
11/10/2004	EP1475091A1 Mycophenolate mofetil - high dose oral suspensions
11/10/2004	EP1475089A1 Process for producing granules containing branched amino acids
11/10/2004	EP1475087A2 A method for chemoprevention of prostate cancer
11/10/2004	EP1475085A1 Controlled-release formulations coated with aqueous dispersions of ethylcellulose
11/10/2004	EP1475084A1 Tablets having improved tabletting characteristics and process for producing the same
11/10/2004	EP1475083A1 Method for producing an active ingredient concentrate, and active ingredient concentrate
11/10/2004	EP1475070A1 Water-in-oil emulsion composition and emulsion cosmetic comprising the same
11/10/2004	EP1475068A2 Process for producing different solid dosage forms
11/10/2004	EP1474438A2 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
11/10/2004	EP1474376A1 Carboxylic acid compounds for use as surfactants
11/10/2004	EP1474196A1 Methods and systems for operating an aerosol generator
11/10/2004	EP1474182A1 Composition for skin healing comprising a chitosan hydrogel
11/10/2004	EP1474174A1 Composition for oral or rectal administration
11/10/2004	EP1474173A2 Composition and method for protecting labile active components
11/10/2004	EP1474172A1 Pharmaceutical compositions for hepatitis c viral protease inhibitors
11/10/2004	EP1474171A1 Weight management system for obese animals
11/10/2004	EP1474162A1 Methods and compositions for the treatment of eye diseases
11/10/2004	EP1474159A2 Compositions containing oat straw and willowherb extract
11/10/2004	EP1474154A2 Improvements in or relating to compositions
11/10/2004	EP1474153A2 Methods for particle-assisted polynucleotide immunization using a pulsed electric field
11/10/2004	EP1474152A1 Orodispersible pharmaceutical composition comprising ivabradine
11/10/2004	EP1474144A1 Controlled release pharmaceutical dosage forms of a cholesteryl ester transfer protein inhibitor
11/10/2004	EP1474142A2 Preparations containing folic acid, vitamin b6, and vitamin b12, and use thereof
11/10/2004	EP1474133A2 Crystalline solids of carvedilol and processes for their preparation
11/10/2004	EP1474125A1 The use of omega-3 polyunsaturated acids ethyl esters in patients suffering from heart failure
11/10/2004	EP1474123A1 Controlled release pharmaceutical formulation containing venlafaxine
11/10/2004	EP1474119A1 Use of extracts containing phytoestrogen selectively modulating estrogen-receptor-beta
11/10/2004	EP1474118A1 Composition for inhalation
11/10/2004	EP1474117A1 Composition for inhalation
11/10/2004	EP1474116A1 Colonic release composition
11/10/2004	EP1474115A1 Non-gelatin capsule shell formulation comprising iota-carrageenan and kappa-carrageenan
11/10/2004	EP1474114A1 Oral dosage form for controlled drug release
11/10/2004	EP1474113A1 Edible pga coating composition
11/10/2004	EP1474112A1 Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping
11/10/2004	EP1474111A1 Sterile lyophilized ifosfamide and associated methods
11/10/2004	EP1474110A1 Depot medicament, carrier materials for depot medicaments, and method for the production thereof
11/10/2004	EP1474109A2 Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs
11/10/2004	EP1474108A2 Liposome drug delivery of polycyclic, aromatic, antioxidant or anti-inflammatory compounds
11/10/2004	EP1474107A2 Efficient liposomal encapsulation under mild conditions
11/10/2004	EP1474106A1 Medicated tampon
11/10/2004	EP1474105A2 Medicated tampon
11/10/2004	EP1474104A2 Demixing-stable granulate
11/10/2004	EP1474103A1 Levothyroxine compositions and methods
11/10/2004	EP1474101A1 Anti-microbial composition comprising a metal ion chelating agent
11/10/2004	EP1474092A1 Micromesh interproximal devices
11/10/2004	EP1474069A1 Control of a biological function
11/10/2004	EP1265570B1 Soluble keratin peptide
11/10/2004	EP1200521B1 Dispersion comprising a non-ionic emulsifier
11/10/2004	EP1194127B1 Method for producing powdery particle-reduced formulations with the aid of compressed gases
11/10/2004	EP1131050B8 Galenic formulations fast disintegrating in the mouth and method for preparing same
11/10/2004	EP1109586B1 External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities
11/10/2004	EP1107750B1 Pharmaceutical composition with antitumor activity on the basis of carboplatin
11/10/2004	EP1061901B1 Nicotine inhaler
11/10/2004	EP1014881B1 System for treating neurodegenerative disorders by infusion of nerve growth factors into the brain
11/10/2004	EP0975348B1 Stabilized tibolone compositions
11/10/2004	EP0958821B1 Fat emulsion containing xanthine derivative
11/10/2004	EP0935460B1 Taste masked pharmaceutical compositions
11/10/2004	EP0923293B1 Treatment of diarrhea
11/10/2004	EP0863774B1 Transdermal therapeutic system for administering active agents to the human body via the skin
11/10/2004	EP0740581B1 Yttria particulate material
11/10/2004	CN2654112Y Capsule for physical method reducing weight
11/10/2004	CN1545522A Hyperbranched amylopectin for use in methods for surgical or therapeutic treatment of mammals or in diagnostic methods expecially for use as a plasma volume expander
11/10/2004	CN1545428A Treatment for ocular infections
11/10/2004	CN1545424A Anti-cancer medicine comprising disintegrin genes and treating methods thereof
11/10/2004	CN1545421A Pharmaceutical compositions of drugs and neutralized acidic polymers
11/10/2004	CN1545420A Topical composition, topical composition precursor, and methods for manufacturing and using
11/10/2004	CN1545414A Organic compounds
11/10/2004	CN1545413A Stabilized formulations of 6-hydroxy-3-(4-[piperidin-1-yl) ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene and salts thereof

1 ... 1913 1914 1915 1916 1917 1918 1919 1920 1921 1922 1923 1924 1925 1926 1927 1928 1929 1930 1931 1932 1933 ... 2991